That experiences leave their trace in the connectivity of the brain has been known for a while, but a pioneering study by researchers at the German Center for Neurodegenerative Diseases (DZNE) and TUD Dresden University of Technology now shows how massive these effects really are.
Zealand Pharma submits NDA for hyperinsulinism drug dasiglucagon
The NDA includes pivotal data from Phase III trials and a long-term extension, with one trial missing its primary endpoint. Credit: Shutterstock / Africa Studio.